MIAMI and LJUBLJANA, Slovenia, Jan. 27 /PRNewswire/ -- Fuisz Pharma today announced the development of a novel anti-abuse system intended for use with abuse prone drugs. This system seeks to address the misuse of addictive drugs with a particular emphasis on opiates and is applicable to all dosage forms.
Mr. Fuisz continued: “The Fuisz system for preventing abuse combines, as the best inventions do, novelty with simplicity. We are confident that our anti-abuse system will be welcomed by our pharmaceutical partners as well as by those concerned with drug misuse issues and the public and private health practitioner.”
Fuisz Pharma is a private pharmaceutical company originated by the Fuiszes. The Fuiszes have made substantial contributions in drug delivery (orally dissolving tablets and novel particle coating systems at Fuisz Technologies; inventing and developing thin film drug delivery technologies at Kosmos Pharma and MonoSol Rx, etc.) and have extensive experience working with big and specialty pharma. Fuisz Pharma has offices in Miami and Los Angeles as well as a presence in the EU through Ljubljana, Slovenia.
CONTACT: Joseph Matus Fuisz of Fuisz Pharma, +1-202-669-5097,
jfuisz@fuisz.com